Literature DB >> 20004859

Febrile seizures and primary human herpesvirus 6 infection.

Ioanna Laina1, Vassiliki P Syriopoulou, George L Daikos, Eleftheria S Roma, Foteini Papageorgiou, Talia Kakourou, Maria Theodoridou.   

Abstract

Primary human herpesvirus 6 infection is acquired mainly during the first two years of life and is often associated with febrile seizures. The aim of the present study was to investigate in Greece the frequency and clinical characteristics of primary human herpesvirus 6 (HHV-6) infection in hospitalized children with febrile seizures. Children aged from 6 months to 5 years without known neurologic disease were examined for primary HHV-6 infection, by real-time polymerase chain reaction in acute-phase plasma and by indirect immunofluorescent assay for antibody titers in acute and convalescent serum. Of 65 children included in the analysis, 55 experienced the first febrile episode of seizures and 10 the second. Primary HHV-6 infection was verified in 10 of 55 children with a first febrile episode (18%), whereas none of the 10 children with a second episode of seizures had primary HHV-6 infection. Eight children were infected with HHV-6 type B and two with type A. None of the 85 control subjects had primary HHV-6 infection, but 49% had immunoglobulin G antibodies against the virus. These findings suggest that primary HHV-6 infection is frequently associated with febrile seizures in children in this geographic region and should be considered, especially for a first episode of febrile seizures.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20004859     DOI: 10.1016/j.pediatrneurol.2009.07.016

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  10 in total

1.  Evaluation of Risk Factors Associated with First Episode Febrile Seizure.

Authors:  Indar Kumar Sharawat; Jitender Singh; Lesa Dawman; Amitabh Singh
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease?

Authors:  Nicholas E Martinez; Fumitaka Sato; Seiichi Omura; Alireza Minagar; J Steven Alexander; Ikuo Tsunoda
Journal:  Pathophysiology       Date:  2012-05-26

Review 3.  Frontier of epilepsy research - mTOR signaling pathway.

Authors:  Chang Hoon Cho
Journal:  Exp Mol Med       Date:  2011-05-31       Impact factor: 8.718

Review 4.  Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation.

Authors:  Anthony L Komaroff; Philip E Pellett; Steven Jacobson
Journal:  Clin Microbiol Rev       Date:  2020-11-11       Impact factor: 26.132

Review 5.  Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.

Authors:  Joseph Ongrádi; Dharam V Ablashi; Tetsushi Yoshikawa; Balázs Stercz; Masao Ogata
Journal:  J Neurovirol       Date:  2016-08-18       Impact factor: 2.643

6.  Prospective case control study of iron deficiency and the risk of febrile seizures in children in South Korea.

Authors:  Han Na Jang; Hoi Soo Yoon; Eun Hye Lee
Journal:  BMC Pediatr       Date:  2019-09-04       Impact factor: 2.125

Review 7.  Human Herpesviruses 6A and 6B in Reproductive Diseases.

Authors:  Anthony L Komaroff; Roberta Rizzo; Jeffrey L Ecker
Journal:  Front Immunol       Date:  2021-03-25       Impact factor: 7.561

8.  Human Herpes Virus Type 6 and Febrile Convulsion.

Authors:  Mohammad Mehdi Houshmandi; Alireza Moayedi; Mohammad Bagher Rahmati; Abdulmajid Nazemi; Darioush Fakhrai; Shahram Zare
Journal:  Iran J Child Neurol       Date:  2015

9.  Seroprevalence of HHV-6 and HHV-8 among blood donors in Greece.

Authors:  Marianna Politou; Dimitrios Koutras; Georgios Kaparos; Serena Valsami; Theodoros Pittaras; Emmanouil Logothetis; George Panayiotakopoulos; Evangelia Kouskouni
Journal:  Virol J       Date:  2014-08-27       Impact factor: 4.099

10.  Stroke-Like Presentation Following Febrile Seizure in a Patient with 1q43q44 Deletion Syndrome.

Authors:  J Elliott Robinson; Stephanie M Wolfe; Kathleen Kaiser-Rogers; Robert S Greenwood
Journal:  Front Neurol       Date:  2016-05-04       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.